Tyra Biosciences, Inc.

NASDAQ:TYRA

12.37 (USD) • At close August 28, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -28.098-28.147-25.571-24.016-18.702-18.192-22.83-21.152-13.272-11.88-12.895-12.509-15.095-14.826-9.93-6.643-5.512-4.209-3.685-2.339-0.002-0.001
Depreciation & Amortization 0.140.1430.1440.1270.1260.1220.1020.0820.0860.0830.0820.0820.0680.0640.050.0410.0270.0220.0190.01600
Deferred Income Tax 000000-4.390005.8470-2.82500.4830000000
Stock Based Compensation 6.386.4226.7027.5734.4114.1154.1864.3772.5292.4332.9091.0192.6883.9721.8680.5070.3380.1740.1270.10600
Change In Working Capital -1.394-3.010.3181.075.774-6.8446.257-0.4531.039-0.483-2.076-0.805-4.8291.863-1.0160.5140.686-0.6651.0070.102-00
Accounts Receivables 0000000000000000000000
Change In Inventory 0000000000000000000000
Change In Accounts Payables 00000-6.90611.3910000.2070.0480.5421.560.0961.2250.745-0.5740.960.13400
Other Working Capital -1.394-3.010.3180.0235.774-6.8446.257-0.4531.039-0.483-2.283-0.853-5.3710.303-1.112-0.711-0.059-0.0910.047-0.032-00
Other Non Cash Items -0.708-0.866-1.183-2.6522.7963.133.1430.0010.0030-5.8470.0012.8250.002-0.4830.0030.3920.2180.00200-0
Operating Cash Flow -23.68-25.458-19.59-17.898-10.258-22.028-13.532-17.145-9.615-9.847-11.98-12.212-17.168-8.925-9.028-5.578-4.461-4.678-2.53-2.115-0.002-0.001
Investing Activities:
Investments In Property Plant And Equipment -0.031-0.014-0.006-0.052-0.47-0.136-0.603-0.083-0.043-0.041-0.021-0.048-0.251-0.239-0.105-0.256-0.24-0.06-0.067-0.108-0-0
Acquisitions Net 0000000000000000.016000000
Purchases Of Investments -20.106-6.87-38.036-36.391-177.406-11.791-143.835000000000000000
Sales Maturities Of Investments 41.00338.91455832.885300000000000000000
Other Investing Activites 0000-0.1450.018-0.144000000000.016000000
Investing Cash Flow 20.86632.0266.95821.557-144.99118.073-144.438-0.083-0.043-0.041-0.021-0.048-0.251-0.239-0.105-0.24-0.24-0.06-0.067-0.108-0-0
Financing Activities:
Debt Repayment 0000000000000000-0.005-0.004-0.004-0.006-0.003-0.004
Common Stock Issued 0.5832.1870.7060.74302000.3240.4670.3700.0030.3640.0270.238-1.509-0.0230.0030.5330000
Common Stock Repurchased 0000-0.251-0.169000000000-0.023000000
Dividends Paid 0000000000000000000000
Other Financing Activities 00000.3730.4840.3240.4670.370.3760.0030000.001183.46-0.731259.779000.11923.332
Financing Cash Flow 0.5832.1870.7060.7430.373200.3150.3240.4670.370.3760000-1.508183.437-0.733130.152-0.004-0.00600.023
Other Information:
Effect Of Forex Changes On Cash 0000000000000000000000
Net Change In Cash -2.2318.755-11.9264.402-154.876196.36-157.646-16.761-9.288-9.512-11.998-11.896-17.392-8.926-10.641177.619-5.434125.414-2.601-2.229-0.0020.022
Cash At End Of Period 99.49101.72192.966104.89299.49254.36658.006216.652233.413242.701252.213264.211276.107293.499302.425313.066135.447140.88115.46718.0680.020.022